1 / 9

Characteristics of studies on lifestyle interventions included in review

Characteristics of studies on lifestyle interventions included in review. Gillies CL, et al. BMJ 2007;334:299-307. Characteristics of studies on pharmacological/herbal interventions included in review. Gillies CL, et al. BMJ 2007;334:299-307.

devin
Download Presentation

Characteristics of studies on lifestyle interventions included in review

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Characteristics of studies on lifestyle interventions included in review Gillies CL, et al. BMJ 2007;334:299-307

  2. Characteristics of studies on pharmacological/herbal interventions included in review Gillies CL, et al. BMJ 2007;334:299-307

  3. Characteristics of studies on pharmacological and lifestyle interventions included in review Gillies CL, et al. BMJ 2007;334:299-307

  4. Information used for the meta-analyses of interventions to prevent or delay type 2 diabete Gillies CL, et al. BMJ 2007;334:299-307

  5. Flowchart of literature search and meta-analysis Gillies CL, et al. BMJ 2007;334:299-307

  6. Meta-analysis of effect of lifestyle interventions on risk of developing type 2 diabetes Gillies CL, et al. BMJ 2007;334:299-307

  7. Meta-analyses of effect of pharmacological and herbal interventions on risk of developing type 2 diabetes Gillies CL, et al. BMJ 2007;334:299-307

  8. Results of meta-regression analyses of interventions to prevent or delay type 2 diabetes Gillies CL, et al. BMJ 2007;334:299-307

  9. Reported adverse events possibly attributable to pharmacological interventions to prevent or delay type 2 diabetes Gillies CL, et al. BMJ 2007;334:299-307

More Related